WallStreetZenWallStreetZen

NASDAQ: BOLD
Boundless Bio Inc Stock

$9.28-0.24 (-2.52%)
Updated May 14, 2024
BOLD Price
$9.28
Fair Value Price
$0.97
Market Cap
$206.52M
52 Week Low
$8.51
52 Week High
$15.24
P/E
N/A
P/B
-1.46x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.83
Operating Cash Flow
N/A
Beta
1.78
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BOLD Overview

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BOLD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BOLD ($9.28) is overvalued by 859.42% relative to our estimate of its Fair Value price of $0.97 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BOLD ($9.28) is not significantly undervalued (859.42%) relative to our estimate of its Fair Value price of $0.97 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BOLD's short-term assets ($112.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more BOLD due diligence checks available for Premium users.

Be the first to know about important BOLD news, forecast changes, insider trades & much more!

BOLD News

Valuation

BOLD fair value

Fair Value of BOLD stock based on Discounted Cash Flow (DCF)
Price
$9.28
Fair Value
$0.97
Overvalued by
859.42%
BOLD ($9.28) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BOLD ($9.28) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

BOLD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-1.46x
Industry
6.05x

BOLD's financial health

Profit margin

Revenue
$0.0
Net Income
-$15.4M
Profit Margin
0%

Assets to liabilities

Assets
$117.1M
Liabilities
$258.3M
Debt to equity
-1.83
BOLD's short-term assets ($112.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BOLD's long-term liabilities ($247.62M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BOLD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BOLD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$15.8M
Investing
$18.1M
Financing
-$924.0k

BOLD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BOLD$206.52M-2.52%N/A-1.46x
TRVI$205.67M+6.96%-8.59x2.84x
INMB$207.52M+5.75%-5.46x7.35x
CRVO$203.87M+1.02%-10.88x38.20x
CDT$209.68M-8.09%-0.00x-67.66x

Boundless Bio Stock FAQ

What is Boundless Bio's quote symbol?

(NASDAQ: BOLD) Boundless Bio trades on the NASDAQ under the ticker symbol BOLD. Boundless Bio stock quotes can also be displayed as NASDAQ: BOLD.

If you're new to stock investing, here's how to buy Boundless Bio stock.

What is the 52 week high and low for Boundless Bio (NASDAQ: BOLD)?

(NASDAQ: BOLD) Boundless Bio's 52-week high was $15.24, and its 52-week low was $8.51. It is currently -39.11% from its 52-week high and 9.05% from its 52-week low.

How much is Boundless Bio's stock price per share?

(NASDAQ: BOLD) Boundless Bio stock price per share is $9.28 today (as of May 14, 2024).

What is Boundless Bio's Market Cap?

(NASDAQ: BOLD) Boundless Bio's market cap is $206.52M, as of May 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Boundless Bio's market cap is calculated by multiplying BOLD's current stock price of $9.28 by BOLD's total outstanding shares of 22,254,537.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.